Cresset Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cresset Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.58M	Buy	13,633 +6	+0%	+$1.05K	0.01%	499
2025 Q4	$2.32M	Buy	13,627 +58	+0.4%	+$8.89K	0.01%	527
2025 Q3	$1.79M	Buy	13,569 +83	+0.6%	+$9.96K	0.01%	570
2025 Q2	$1.43M	Sell	13,486 -1,050	-7%	-$114K	0.01%	587
2025 Q1	$1.8M	Sell	14,536 -2,307	-14%	-$301K	0.01%	570
2024 Q4	$2.07M	Sell	16,843 -16,606	-50%	-$1.96M	0.01%	541
2024 Q3	$3.73M	Buy	33,449 +14,905	+80%	+$1.63M	0.01%	537
2024 Q2	$1.98M	Buy	18,544 +1,893	+11%	+$208K	0.01%	727
2024 Q1	$2.01M	Buy	16,651 +14,266	+598%	+$1.75M	0.01%	639
2023 Q4	$293K	Sell	2,385 -1,446	-38%	-$180K	﹤0.01%	1500
2023 Q3	$496K	Buy	3,831 +1,111	+41%	+$148K	﹤0.01%	1185
2023 Q2	$337K	Buy	+2,720	New	+$366K	﹤0.01%	1473
2019 Q2	–	Sell	-485	Closed	-$69K	–	1071
2019 Q1	$69K	Buy	485 +262	+117%	+$34.2K	﹤0.01%	674
2018 Q4	$28K	Buy	+223	New	+$33.1K	﹤0.01%	643

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Cresset Asset Management's JAZZ Position: Q1 2026 in Review

Cresset Asset Management increased its Jazz Pharmaceuticals (JAZZ) stake by 0.04% in Q1 2026, buying an estimated $1.05K and bringing the position to 13,633 shares worth $2.58M. The position accounts for 0.01% of the portfolio, ranked #499.

Cresset Asset Management first reported a position in JAZZ in Q4 2018 and has held it in 14 quarters since. The position peaked at $3.73M in Q3 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Cresset Asset Management held 13,633 shares of Jazz Pharmaceuticals worth $2.58M as of Q1 2026.
Cresset Asset Management bought 6 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.05K.
Jazz Pharmaceuticals made up 0.01% of Cresset Asset Management's portfolio in Q1 2026, its #499 holding.
Cresset Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2018 and has held it in 14 quarters since.
Cresset Asset Management's Jazz Pharmaceuticals position peaked at $3.73M in Q3 2024.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.